Last reviewed · How we verify
Eyelid cleansing wipes
Eyelid cleansing wipes mechanically remove debris, oils, and biofilm from the eyelid margin to maintain ocular hygiene and reduce irritation.
Eyelid cleansing wipes mechanically remove debris, oils, and biofilm from the eyelid margin to maintain ocular hygiene and reduce irritation. Used for Eyelid hygiene and cleansing, Blepharitis management, Meibomian gland dysfunction support.
At a glance
| Generic name | Eyelid cleansing wipes |
|---|---|
| Sponsor | Shaare Zedek Medical Center |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
These wipes are a topical hygiene product designed to cleanse the eyelid edges and lashes, removing accumulated secretions, cosmetics, and bacterial biofilm that can contribute to conditions like blepharitis and meibomian gland dysfunction. The mechanical action combined with mild cleansing agents helps restore normal eyelid health and reduce inflammation associated with poor eyelid hygiene.
Approved indications
- Eyelid hygiene and cleansing
- Blepharitis management
- Meibomian gland dysfunction support
Common side effects
- Mild eye irritation
- Temporary stinging or discomfort
Key clinical trials
- Treatment of Blepharitis Induced by Demodex Folliculorum Through Eyelid Cleansing With Wipes Containing Topical Chlorhexidine (PHASE4)
- Efficacy of EPD-09-25 for Eyelid Hygiene Before and After Eye Surgery. (NA)
- The Effect of a Pre-cataract Surgical Ocular Hygiene Regime on Microbial Load, Tear Osmolarity, Dry Eye, and Inflammatory Markers (PHASE4)
- Treatment of Blepharitis With Povidone-Iodine 1% (NA)
- Treatment of Anterior Blepharitis With Microblepharoexfoliation Procedure (NA)
- Treatment of Ocular Demodicosis by Cleansing the Eyelid Margins Combined With Tea Tree Oil Ointment (NA)
- Evaluation of Treatment Option for Demodicosis in Patients Undergoing Cataract Surgery (PHASE2, PHASE3)
- To Compare Blephapad Combo vs Standard Treatment for Eyelid Cleansing in Bilateral Posterior Blepharitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Eyelid cleansing wipes CI brief — competitive landscape report
- Eyelid cleansing wipes updates RSS · CI watch RSS
- Shaare Zedek Medical Center portfolio CI